Evaluating Apelin as a Potential Biomarker in Major Depressive Disorder: Its Correlation with Clinical Symptomatology
International Journal of Molecular Sciences · 20.12.2024 · 25 (24) · 13663
DOI: 10.3390/ijms252413663 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 20.12.2024. Verfasst von Enkhmurun Chibaatar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, University of Occupational and Environmental Health, Kitakyushu 807-8555, Japan. Hauptthemen laut MEDLINE: Apelin, Major Depressive Disorder, Biomarkers. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Occupational and Environmental Health.
Abstract (Originalsprache)
To date, only a limited number of studies have investigated the potential effects of apelin on mood regulation and emotional behavior. Therefore, this study investigated apelin’s role in major depressive disorder (MDD) by comparing the serum and plasma apelin concentrations between 30 patients with MDD and 30 healthy controls (HCs), and the correlated serum and plasma apelin levels and the severity of depressive symptoms using the Montgomery–Åsberg Depression Rating Scale (MADRS). Blood samples were collected following 12 h of fasting, and the apelin levels were measured using an ELISA kit. The serum apelin concentrations showed no significant difference between the MDD and HC groups, while the plasma apelin levels were significantly lower in the MDD group (p = 0.002). Among the patients with MDD, a positive moderate correlation was observed between the total MADRS scores and plasma apelin levels (r = 0.439), with statistical significance (p < 0.05). Additionally, significant positive correlations (p < 0.05) were found between both the serum and plasma apelin levels and the MADRS subscales 5 (reduced appetite) and 6 (concentration difficulties). These preliminary findings, although not definitive, suggest that apelin profiles may help to identify distinct subgroups within MDD patients, warranting further investigation into the different apelin isoforms and their associations in different populations of MDD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, University of Occupational and Environmental Health, Kitakyushu 807-8555, Japan.
- Wakamatsu Hospital, University of Occupational and Environmental Health, Kitakyushu 808-0024, Japan.
ORCID-Profile: Enkhmurun Chibaatar, Atsuko Ikenouchi, Naomichi Okamoto, Tomoya Natsuyama
Förderung
- University of Occupational and Environmental Health
Zitieren
APA
Chibaatar, E., Fujii, R., Ikenouchi, A., Okamoto, N., Natsuyama, T., Hayasaki, G., Shinkai, T., & Yoshimura, R. (2024). Evaluating Apelin as a Potential Biomarker in Major Depressive Disorder: Its Correlation with Clinical Symptomatology. International Journal of Molecular Sciences, 25(24), 13663. https://doi.org/10.3390/ijms252413663
Vancouver
Chibaatar E, Fujii R, Ikenouchi A, Okamoto N, Natsuyama T, Hayasaki G, et al. Evaluating Apelin as a Potential Biomarker in Major Depressive Disorder: Its Correlation with Clinical Symptomatology. International Journal of Molecular Sciences. 2024;25(24):13663. doi:10.3390/ijms252413663
BibTeX
@article{Chibaatar2024,
author = {Chibaatar, Enkhmurun and Fujii, Rintarou and Ikenouchi, Atsuko and Okamoto, Naomichi and Natsuyama, Tomoya and Hayasaki, Gaku and Shinkai, Takahiro and Yoshimura, Reiji},
title = {Evaluating Apelin as a Potential Biomarker in Major Depressive Disorder: Its Correlation with Clinical Symptomatology},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {24},
pages = {13663},
doi = {10.3390/ijms252413663}
}
EUVIMED